Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis

John B O'Connor1, Madison Mottlowitz1, Monica E Kruk2

  • 1Department of Pediatrics, Division of Pulmonary and Sleep Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.

Insights

Cystic fibrosis (CF) lung disease involves complex airway inflammation and infection. This study reveals unique metabolic profiles in CF airways, linking specific metabolites to bacterial communities and disease severity, offering new insights into CF progression.

Area of Science:

  • Pulmonary Medicine and Microbiology
  • Metabolomics and Multi-omics Analysis

Background:

  • Cystic fibrosis (CF) is characterized by progressive lung disease driven by chronic airway infection and inflammation.
  • The precise drivers of CF airway pathology remain incompletely understood.
  • Metabolomics offers a physiological snapshot of the airway environment, aiding in the study of complex disease processes.

Purpose of the Study:

  • To characterize the airway metabolome in individuals with CF (PWCF) and disease controls (DC).
  • To investigate correlations between airway metabolites, microbiome composition, and markers of inflammation and bacterial burden.
  • To identify novel multi-omic relationships driving CF lung disease.

Main Methods:

  • Targeted liquid chromatography-mass spectrometry (LC-MS) was used to analyze 409 metabolites in bronchoalveolar lavage fluid (BALF).
  • Bacterial profiling was performed using 16S sequencing, and total bacterial load (TBL) was quantified via qPCR.
  • Multi-omic network analysis (SsCCNet) integrated metabolomic, microbiome, and clinical data.

Main Results:

  • The CF airway metabolome showed significantly increased amino acids and decreased acylcarnitines compared to controls.
  • Amino acids and acylcarnitines correlated strongly with inflammation markers (WBC, neutrophils) and bacterial load.
  • Network analysis revealed specific correlations between metabolites (e.g., L-methionine-S-oxide), CF pathogens (Staphylococcus), and other bacterial taxa (Prevotella).

Conclusions:

  • This study identified distinct metabolomic signatures in the airways of individuals with CF.
  • Metabolomic profiles are closely linked to airway bacterial communities and inflammatory processes in CF.
  • These multi-omic findings provide a foundation for further research into CF pathogenesis and potential therapeutic targets.